LYFIX vs. IBB
Compare and contrast key facts about AlphaCentric LifeSci Healthcare Fund (LYFIX) and iShares Nasdaq Biotechnology ETF (IBB).
LYFIX is managed by AlphaCentric Funds. It was launched on Nov 28, 2019. IBB is a passively managed fund by iShares that tracks the performance of the NASDAQ Biotechnology Index. It was launched on Feb 5, 2001.
Scroll down to visually compare performance, riskiness, drawdowns, and other indicators and decide which better suits your portfolio: LYFIX or IBB.
Key characteristics
| LYFIX | IBB | |
|---|---|---|
| YTD Return | 9.13% | 8.69% |
| 1Y Return | 8.97% | 17.71% |
| 3Y Return (Ann) | 2.32% | -5.04% |
| Sharpe Ratio | 0.42 | 1.03 |
| Daily Std Dev | 21.66% | 17.70% |
| Max Drawdown | -35.33% | -62.85% |
| Current Drawdown | -2.86% | -15.61% |
Correlation
The correlation between LYFIX and IBB is 0.82, which is considered to be high. That indicates a strong positive relationship between their price movements. Having highly-correlated positions in a portfolio may signal a lack of diversification, potentially leading to increased risk during market downturns.
Performance
LYFIX vs. IBB - Performance Comparison
The year-to-date returns for both stocks are quite close, with LYFIX having a 9.13% return and IBB slightly lower at 8.69%. The chart below displays the growth of a $10,000 investment in both assets, with all prices adjusted for splits and dividends.
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
LYFIX vs. IBB - Expense Ratio Comparison
LYFIX has a 1.40% expense ratio, which is higher than IBB's 0.47% expense ratio.
Risk-Adjusted Performance
LYFIX vs. IBB - Risk-Adjusted Performance Comparison
This table presents a comparison of risk-adjusted performance metrics for AlphaCentric LifeSci Healthcare Fund (LYFIX) and iShares Nasdaq Biotechnology ETF (IBB). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Dividends
LYFIX vs. IBB - Dividend Comparison
LYFIX's dividend yield for the trailing twelve months is around 2.41%, more than IBB's 0.27% yield.
| TTM | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
LYFIX AlphaCentric LifeSci Healthcare Fund | 2.41% | 2.63% | 4.43% | 12.88% | 2.30% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
IBB iShares Nasdaq Biotechnology ETF | 0.27% | 0.26% | 0.31% | 0.21% | 0.21% | 0.17% | 0.20% | 0.30% | 0.19% | 0.03% | 0.15% | 0.03% |
Drawdowns
LYFIX vs. IBB - Drawdown Comparison
The maximum LYFIX drawdown since its inception was -35.33%, smaller than the maximum IBB drawdown of -62.85%. Use the drawdown chart below to compare losses from any high point for LYFIX and IBB. For additional features, visit the drawdowns tool.
Volatility
LYFIX vs. IBB - Volatility Comparison
AlphaCentric LifeSci Healthcare Fund (LYFIX) and iShares Nasdaq Biotechnology ETF (IBB) have volatilities of 3.58% and 3.60%, respectively, indicating that both stocks experience similar levels of price fluctuations. This suggests that the risk associated with both stocks, as measured by volatility, is nearly the same. The chart below showcases a comparison of their rolling one-month volatility.